Suppr超能文献

干细胞和外泌体治疗硫芥诱导的组织损伤的疗效。

Therapeutic Benefits of Stem Cells and Exosomes for Sulfur-Mustard-Induced Tissue Damage.

机构信息

Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, NC 27101, USA.

Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.

出版信息

Int J Mol Sci. 2023 Jun 9;24(12):9947. doi: 10.3390/ijms24129947.

Abstract

Sulfur mustard (SM) is a highly toxic chemical agent that causes severe tissue damage, particularly to the eyes, lungs, and skin. Despite advances in treatment, there is a need for more effective therapies for SM-induced tissue injury. Stem cell and exosome therapies are emerging as promising approaches for tissue repair and regeneration. Stem cells can differentiate into multiple cell types and promote tissue regeneration, while exosomes are small vesicles that can deliver therapeutic cargo to target cells. Several preclinical studies demonstrated the potential of stem cell, exosome, or combination therapy for various tissue injury, showing improvements in tissue repairing, inflammation, and fibrosis. However, there are also challenges associated with these therapies, such as the requirement for standardized methods for exosome isolation and characterization, the long-term safety and efficacy and reduced SM-induced tissue injury of these therapies. Stem cell or exosome therapy was used for SM-induced eye and lung injury. Despite the limited data on the use for SM-induced skin injury, this therapy is a promising area of research and may offer new treatment options in the future. In this review, we focused on optimizing these therapies, evaluating their safety and efficacy, and comparing their efficacy to other emerging therapeutic approaches potentially for SM-induced tissue injury in the eye, lung, and skin.

摘要

芥子气(SM)是一种剧毒化学战剂,会导致严重的组织损伤,特别是对眼睛、肺部和皮肤。尽管在治疗方面取得了进展,但仍需要更有效的疗法来治疗 SM 引起的组织损伤。干细胞和外泌体疗法作为组织修复和再生的有前途的方法正在出现。干细胞可以分化为多种细胞类型并促进组织再生,而外泌体是可以将治疗性货物递送到靶细胞的小囊泡。一些临床前研究表明,干细胞、外泌体或联合治疗对各种组织损伤具有潜力,显示出在组织修复、炎症和纤维化方面的改善。然而,这些疗法也存在一些挑战,例如需要标准化的外泌体分离和表征方法,长期安全性和有效性,以及这些疗法对 SM 引起的组织损伤的疗效降低。干细胞或外泌体疗法已用于治疗 SM 引起的眼部和肺部损伤。尽管关于 SM 引起的皮肤损伤的使用数据有限,但该疗法是一个有前途的研究领域,将来可能会提供新的治疗选择。在这篇综述中,我们专注于优化这些疗法,评估其安全性和疗效,并比较它们在治疗 SM 引起的眼部、肺部和皮肤组织损伤方面的疗效与其他新兴治疗方法的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce28/10298660/e69623c68a4c/ijms-24-09947-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验